Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydroxypropyl methylcellulose E15 is a specific grade of hydroxypropyl methylcellulose (HPMC), a semisynthetic, inert, and viscoelastic polymer derived from cellulose. It is widely utilized in the pharmaceutical industry as an excipient, functioning as a film-forming agent, binder, and a controlled-release component in oral solid preparations, where it enhances stability, dissolution rates, and water retention. Additionally, it serves as an active ingredient in ophthalmic solutions, commonly known as artificial tears, to alleviate symptoms of dry eyes by lubricating the ocular surface and stabilizing the tear film. The "E15" designation refers to its viscosity grade, typically around 15 mPa·s or 15 cP.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hydroxypropyl methylcellulose E15.